Found: 50
Select item for more details and to access through your institution.
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33042-0
- By:
- Publication type:
- Article
Quantifying subclinical central nervous lesions in primary antiphospholipid syndrome: The role of magnetization transfer imaging.
- Published in:
- Journal of Magnetic Resonance Imaging, 2008, v. 27, n. 3, p. 483, doi. 10.1002/jmri.21308
- By:
- Publication type:
- Article
Cerebrovascular disease in patients with antiphospholipid antibody syndrome: a transcranial Doppler and magnetic resonance imaging study.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae060
- By:
- Publication type:
- Article
Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2315872, doi. 10.1001/jamanetworkopen.2023.15872
- By:
- Publication type:
- Article
Impact of Distinct Therapies on Antibody Response to SARS‐CoV‐2 Vaccine in Systemic Lupus Erythematosus.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 4, p. 562, doi. 10.1002/acr.24824
- By:
- Publication type:
- Article
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease.
- Published in:
- Arthritis Care & Research, 2021, v. 73, n. 12, p. 1804, doi. 10.1002/acr.24391
- By:
- Publication type:
- Article
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.604602
- By:
- Publication type:
- Article
William Habib Chahade 5th October 1941-4th January 2017.
- Published in:
- 2017
- By:
- Publication type:
- Obituary
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 480, doi. 10.1093/rheumatology/keac301
- By:
- Publication type:
- Article
Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS).
- Published in:
- Rheumatology, 2021, v. 60, n. 1, p. 179, doi. 10.1093/rheumatology/keaa252
- By:
- Publication type:
- Article
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution.
- Published in:
- Rheumatology, 2020, v. 59, n. 9, p. 2412, doi. 10.1093/rheumatology/kez620
- By:
- Publication type:
- Article
Pregnancy outcomes in mixed connective tissue disease: a multicentre study.
- Published in:
- Rheumatology, 2019, v. 58, n. 11, p. 2000, doi. 10.1093/rheumatology/kez141
- By:
- Publication type:
- Article
Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis.
- Published in:
- Rheumatology, 2018, v. 57, n. 10, p. 1721, doi. 10.1093/rheumatology/kex330
- By:
- Publication type:
- Article
Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 1, p. 13, doi. 10.1007/s40272-021-00484-w
- By:
- Publication type:
- Article
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition.
- Published in:
- Advances in Rheumatology, 2023, v. 63, n. 1, p. 1, doi. 10.1186/s42358-023-00309-z
- By:
- Publication type:
- Article
Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 8, p. 2105, doi. 10.1007/s10067-023-06613-9
- By:
- Publication type:
- Article
Interferon-α and Angiogenic Dysregulation in Pregnant Lupus Patients Who Develop Preeclampsia.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Interferon-α and Angiogenic Dysregulation in Pregnant Lupus Patients Who Develop Preeclampsia.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 4, p. 977, doi. 10.1002/art.39029
- By:
- Publication type:
- Article
Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 10, p. 1, doi. 10.1007/s11926-016-0611-y
- By:
- Publication type:
- Article
Emerging Therapies in Antiphospholipid Syndrome.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 4, p. 22, doi. 10.1007/s11926-016-0566-z
- By:
- Publication type:
- Article
Difficult Clinical Situations in the Antiphospholipid Syndrome.
- Published in:
- Current Rheumatology Reports, 2015, v. 17, n. 4, p. 1, doi. 10.1007/s11926-015-0502-7
- By:
- Publication type:
- Article
ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
- Published in:
- Journal of Thrombosis & Thrombolysis, 2015, v. 40, n. 3, p. 374, doi. 10.1007/s11239-015-1176-8
- By:
- Publication type:
- Article
Systemic sclerosis induced by the use of cocaine: is there an association?
- Published in:
- Rheumatology International, 2019, v. 39, n. 2, p. 387, doi. 10.1007/s00296-018-4227-6
- By:
- Publication type:
- Article
Eosinophilic fasciitis during pregnancy: case report and review of literature.
- Published in:
- Rheumatology International, 2018, v. 38, n. 3, p. 525, doi. 10.1007/s00296-017-3908-x
- By:
- Publication type:
- Article
The importance of recognizing antiphospholipid syndrome in vascular medicine.
- Published in:
- Jornal Vascular Brasileiro, 2017, v. 16, n. 2, p. 140, doi. 10.1590/1677-5449.011416
- By:
- Publication type:
- Article
High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis.
- Published in:
- Rheumatology International, 2012, v. 32, n. 6, p. 1549, doi. 10.1007/s00296-011-1821-2
- By:
- Publication type:
- Article
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
- Published in:
- Advances in Rheumatology, 2022, v. 62, n. 1, p. 1, doi. 10.1186/s42358-022-00268-x
- By:
- Publication type:
- Article
Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS).
- Published in:
- Advances in Rheumatology, 2020, v. 60, n. 1, p. 1, doi. 10.1186/s42358-020-00125-9
- By:
- Publication type:
- Article
Anti-collagen type v: a marker of early systemic sclerosis?
- Published in:
- Advances in Rheumatology, 2019, v. 59, n. 1, p. N.PAG, doi. 10.1186/s42358-019-0063-y
- By:
- Publication type:
- Article
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 10, p. 1687, doi. 10.1002/art.42624
- By:
- Publication type:
- Article
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 8, p. 1407, doi. 10.1002/art.42489
- By:
- Publication type:
- Article
Fluctuation of Anti–Domain 1 and Anti–β<sub>2</sub>‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 6, p. 984, doi. 10.1002/art.42459
- By:
- Publication type:
- Article
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40222-5
- By:
- Publication type:
- Article
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40222-5
- By:
- Publication type:
- Article
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis.
- Published in:
- Systematic Reviews, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s13643-021-01754-x
- By:
- Publication type:
- Article
Ocular findings in asymptomatic patients with primary antiphospholipid syndrome.
- Published in:
- Lupus, 2022, v. 31, n. 14, p. 1800, doi. 10.1177/09612033221133687
- By:
- Publication type:
- Article
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
- Published in:
- Lupus, 2022, v. 31, n. 14, p. 1770, doi. 10.1177/09612033221128742
- By:
- Publication type:
- Article
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
- Published in:
- Lupus, 2022, v. 31, n. 8, p. 974, doi. 10.1177/09612033221102073
- By:
- Publication type:
- Article
CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
- Published in:
- Lupus, 2022, v. 31, n. 5, p. 565, doi. 10.1177/09612033221086134
- By:
- Publication type:
- Article
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
- Published in:
- Lupus, 2021, v. 30, n. 14, p. 2276, doi. 10.1177/09612033211062523
- By:
- Publication type:
- Article
Distinct features of youth-onset primary antiphospholipid syndrome.
- Published in:
- Lupus, 2021, v. 30, n. 12, p. 1888, doi. 10.1177/09612033211038054
- By:
- Publication type:
- Article
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?
- Published in:
- Lupus, 2021, v. 30, n. 11, p. 1732, doi. 10.1177/09612033211033978
- By:
- Publication type:
- Article
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
- Published in:
- Lupus, 2020, v. 29, n. 12, p. 1571, doi. 10.1177/0961203320950461
- By:
- Publication type:
- Article
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
- Published in:
- Lupus, 2020, v. 29, n. 11, p. 1353, doi. 10.1177/0961203320940776
- By:
- Publication type:
- Article
Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
- Published in:
- Lupus, 2020, v. 29, n. 7, p. 676, doi. 10.1177/0961203320916527
- By:
- Publication type:
- Article
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 11, p. 1, doi. 10.1371/journal.pntd.0010002
- By:
- Publication type:
- Article